Current status and future perspective of radiopharmaceuticals in China

被引：23

作者：

Hu, Ji ^{[1
]}

Li, Hongyu ^{[1
]}

Sui, Yanying ^{[1
]}

Du, Jin ^{[1
,2
]}

机构：

[1] HighTech Atom Co Ltd, 1 Sanqiang Rd, Beijing 102413, Peoples R China

[2] China Isotope & Radiat Corp, 66 Changwa Zhongjie, Beijing 100089, Peoples R China

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / 08期

关键词：

Radiopharmaceuticals; Current status; Radionuclides; Theranostic; Future perspective; SMALL-ANIMAL SPECT/CT; BIOLOGICAL EVALUATION; LOW LIPOPHILICITY; LIVER FIBROSIS; PET; RADIOTRACER; TOMOGRAPHY; RADIOLIGAND; DERIVATIVES; CANCER;

D O I：

10.1007/s00259-021-05615-6

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Radiopharmaceuticals are essential components of nuclear medicine and serve as one of the cornerstones of molecular imaging and precision medicine. They provide new means and approaches for early diagnosis and treatment of diseases. After decades of development and hard efforts, a relatively matured radiopharmaceutical production and management system has been established in China with high-quality facilities. This review provides an overview of the current status of radiopharmaceuticals on production and distribution, clinical application, and regulatory supervision and also describes some important advances in research and development and clinical translation of radiopharmaceuticals in the past 10 years. Moreover, some prospects of research and development of radiopharmaceuticals in the near future are discussed.

引用

页码：2514 / 2530

页数：17

共 93 条

[1] The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET) [J].

Banister, Samuel D. ;

Manoli, Miral ;

Kassiou, Michael .

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (3-4) :215-224

[2] Synergy between amyloid-β and tau in Alzheimer's disease [J].

Busche, Marc Aurel ;

Hyman, Bradley T. .

NATURE NEUROSCIENCE, 2020, 23 (10) :1183-1193

[3] Side Chain Optimization Remarkably Enhances the in Vivo Stability of 18F-Labeled Glutamine for Tumor Imaging [J].

Chen, Junyi ;

Li, Cong ;

Hong, Hanyu ;

Liu, Hui ;

Wang, Chunhong ;

Xu, Mengxin ;

Han, Yuxiang ;

Liu, Zhibo .

MOLECULAR PHARMACEUTICS, 2019, 16 (12) :5035-5041

[4]

Chen Y, 2012, J ISOTOPES, V25, P144, DOI [10.7538/tws.2012.25.03.0144, DOI 10.7538/TWS.2012.25.03.0144]

[5]

Cui M, 2019, China Patent, Patent No. 109704988

[6] Synthesis and Evaluation of Novel 18F Labeled 2-Pyridinylbenzoxazole and 2-Pyridinylbenzothiazole Derivatives as Ligands for Positron Emission Tomography (PET) Imaging of β-Amyloid Plaques [J].

Cui, Mengchao ;

Wang, Xuedan ;

Yu, Pingrong ;

Zhang, Jinming ;

Li, Zijing ;

Zhang, Xiaojun ;

Yang, Yanping ;

Ono, Masahiro ;

Jia, Hongmei ;

Saji, Hideo ;

Liu, Boli .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (21) :9283-9296

[7]

Deng X, 2009, J ISOTOPES, V22, P71

[8]

[邓雪松 Deng Xuesong], 2016, [原子能科学技术, Atomic Energy Science and Technology], V50, P1324

[9] Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism [J].

Ding, Jie ;

Zhang, Yushi ;

Wen, Jin ;

Zhang, Hui ;

Wang, Huiping ;

Luo, Yaping ;

Pan, Qingqing ;

Zhu, Wenjia ;

Wang, Xuezhu ;

Yao, Shaobo ;

Kreissl, Michael C. ;

Hacker, Marcus ;

Tong, Anli ;

Huo, Li ;

Li, Xiang .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (11) :2656-2665

[10] 68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent [J].

Duan, Xiaojiang ;

Cao, Zhen ;

Zhu, Hua ;

Liu, Chen ;

Zhang, Xiaojun ;

Zhang, Jinming ;

Ren, Ya'nan ;

Liu, Futao ;

Cai, Xuekang ;

Guo, Xiaoyi ;

Xi, Zhen ;

Pomper, Martin G. ;

Yang, Zhi ;

Fan, Yan ;

Yang, Xing .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (03) :1030-1040

← 1 2 3 4 5 6 7 8 9 10 →